Author

Molly Gale

Institution: Yale University

Observed institutions: Translational Genomics Research Institute, Yale University

OpenAlex ID: A5061635016

An easy and efficient inducible CRISPR/Cas9 platform with improved specificity for multiple gene targeting

2016 · Jian Cao, Lizhen Wu, et al. · Nucleic Acids Research · 218

Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds

2016 · John R. Horton, Xu Liu, et al. · Cell chemical biology · 105

Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance

2016 · Molly Gale, Joyce Sayegh, et al. · Oncotarget · 85

Acquired Resistance of EGFR-Mutant Lung Adenocarcinomas to Afatinib plus Cetuximab Is Associated with Activation of mTORC1

2014 · Valentina Pirazzoli, Caroline Nebhan, et al. · Cell Reports · 72

Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition

2019 · Molly Gale, Yao Li, et al. · Cancer Research · 51

DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription

2012 · Sungwon Jung, Seungchan Kim, et al. · PLoS ONE · 23

High-throughput screening to identify inhibitors of lysine demethylases

2015 · Molly Gale, Qin Yan · Epigenomics · 19

Differential effects of AKT1(p.E17K) expression on human mammary luminal epithelial and myoepithelial cells

2012 · Bodour Salhia, Courtney Van Cott, et al. · Human Mutation · 15

The Molecular Basis of Histone Demethylation

2017 · John R. Horton, Molly Gale, et al. · Cancer drug discovery and develogment/Cancer drug discovery and development · 10

DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription

2012 · Sungwon Jung, Kim Seungchan, et al. · Blood · 2

The Role of the Histone Demethyltransferase Gene JMJD1C and H3K9 Methylation in Multiple Myeloma

2012 · Janine LoBello, Molly Gale, et al. · Blood · 1

Data from Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition

2023 · Molly Gale, Yao Li, et al.

Supplementary Tables 2-13 from Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition

2023 · Molly Gale, Yao Li, et al.

Supplementary Figures 1-11, Table 1, method and references from Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition

2023 · Molly Gale, Yao Li, et al.

Works count: 14

Citation count: 601

H-index: 9

I10-index: 9